Denise Grathwohl

机构：University of Würzburg, Universitätsklinikum Würzburg

发表论文 8 篇 · 总被引 66 次 · h-index 4

代表论文

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis (2023 · Frontiers in Immunology · 被引 21)
Impaired T cells and “memory-like” NK-cell reconstitution is linked to late-onset HCMV reactivation after letermovir cessation (2024 · Blood Advances · 被引 18)
Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab (“Pom‐PAD‐Dara”) in relapsed/refractory multiple myeloma (2020 · Cancer Medicine · 被引 15)
Obinutuzumab and venetoclax induced complete remission in a patient with ibrutinib‐resistant non‐nodal leukemic mantle cell lymphoma (2020 · European Journal Of Haematology · 被引 6)
Reliable and Interpretable Mortality Prediction With Strong Foresight in COVID-19 Patients: An International Study From China and Germany (2021 · Frontiers in Artificial Intelligence · 被引 4)
Multi-agent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone and daratumumab (Pom-PAD-Dara) in relapsed/ refractory multiple myeloma (2019 · Clinical Lymphoma Myeloma & Leukemia · 被引 2)